Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate
- PMID: 2498936
- DOI: 10.1007/BF00442260
Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate
Abstract
Sixteen male smokers, abstinent the morning before testing, were assessed under four conditions: placebo chewing gum, 2 mg nicotine chewing gum, 4 mg nicotine gum, and cigarette smoking. Placebo gum was administered in the cigarette condition, while sham smoking occurred in the gum conditions. Pre-drug administration and post-drug difference scores were calculated for each assessment measure: rapid visual information processing (RVIP), memory for new information, and heart rate. Nicotine raised heart rate in a significant monotonic dose-related manner (P less than 0.001): placebo +0.2; 2 mg gum +5.1; 4 mg gum +9.8; cigarette +17.5 bpm. Rapid visual information processing target detections were also significantly related to dose (P less than 0.01), with this increased vigilance significant under 4 mg nicotine gum and cigarette smoking. Memory task performance was not significantly affected. Self-reported feelings of alertness/energy were higher while smoking than under placebo or 4 mg gum. Complaints about the taste of the 4 mg nicotine gum were frequent.
Similar articles
-
Cigarette smoking and nicotine gum (0, 2 and 4 mg): effects upon four visual attention tasks.Neuropsychobiology. 1992;25(1):34-43. doi: 10.1159/000118807. Neuropsychobiology. 1992. PMID: 1603292
-
Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.Physiol Behav. 2005 Jan 17;83(5):833-43. doi: 10.1016/j.physbeh.2004.10.005. Epub 2004 Nov 23. Physiol Behav. 2005. PMID: 15639169 Clinical Trial.
-
Nicotine gum: dose-related effects on cigarette smoking and subjective ratings.Psychopharmacology (Berl). 1987;92(4):424-30. doi: 10.1007/BF00176472. Psychopharmacology (Berl). 1987. PMID: 3114794 Clinical Trial.
-
Effects of the nicotine patch on performance during the first week of smoking cessation.Nicotine Tob Res. 2003 Apr;5(2):169-80. doi: 10.1080/1462220031000074873. Nicotine Tob Res. 2003. PMID: 12745489 Review.
-
Pharmacokinetic considerations in understanding nicotine dependence.Ciba Found Symp. 1990;152:186-200; discussion 200-9. doi: 10.1002/9780470513965.ch11. Ciba Found Symp. 1990. PMID: 2209254 Review.
Cited by
-
Smoking deprivation in "early" and "late" smokers and memory functions.Psychopharmacology (Berl). 1992;106(2):253-60. doi: 10.1007/BF02801981. Psychopharmacology (Berl). 1992. PMID: 1549651
-
Non-stimulant treatments for ADHD.Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I51-9. doi: 10.1007/s007870070019. Eur Child Adolesc Psychiatry. 2000. PMID: 11140780 Review.
-
A Risk Assessment Matrix for Public Health Principles: The Case for E-Cigarettes.Int J Environ Res Public Health. 2017 Mar 31;14(4):363. doi: 10.3390/ijerph14040363. Int J Environ Res Public Health. 2017. PMID: 28362360 Free PMC article.
-
Facilitation of memory by post-trial administration of nicotine: evidence for an attentional explanation.Psychopharmacology (Berl). 1992;108(4):452-5. doi: 10.1007/BF02247420. Psychopharmacology (Berl). 1992. PMID: 1410158
-
Mood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs.Brain Sci. 2018 Mar 13;8(3):43. doi: 10.3390/brainsci8030043. Brain Sci. 2018. PMID: 29533974 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical